(1 - 14 von 14
)
OPUS Clients in the News Archives - Opus Biotech Communications
opusbiotech.com
Inside Perspectives on Cancer Immunotherapy: An Interview with TCR2 The…utics CEO Garry Menzel. On May 19, OPUS Clients in the News.
Immunotherapy company TCR2 The…utics plans $100M IPOwww.spglobal.com › news-insights › trending
www.spglobal.com
· Garry Menzel, who has previously led the biotechnology practices for Goldman Sachs & Co. LLC and Credit Suisse Group AG, is serving as CEO ...
TCR2 The…utics and CGT Catapult join forces at UK Bioscience ...www.manufacturingchemist.com › ... › Directory
· Garry Menzel, President and CEO of TCR2 The…utics, said: "The agreement with CGT Catapult enables us to meet our immediate clinical ...
TCR2 chooses bigger expansion for cancer therapy manufacturingcleanroomtechnology.com › news › article_page
cleanroomtechnology.com
· trial and the clinical plans for our next-generation TRuC-T cell products," said Garry Menzel, President and CEO of TCR2 The…utics.
sortiert nach Relevanz / Datum